Phreesia Inc
NYSE:PHR
Phreesia Inc
NYSE:PHR
Price:
20.61 USD
0.73%
Market Closed
Updated:
Apr 28, 2024
Section:
Relative Value
The Relative Value of one
PHR
stock under the Base Case scenario is
39.71
USD.
Compared to the current market price of 20.61 USD,
Phreesia Inc
is
Undervalued by 48%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHR
Relative Value
Base Case
39.71
USD
Undervaluation 48%
Valuation Multiples
Multiples Across Competitors
PHR Competitors Multiples
Phreesia Inc Competitors
Phreesia Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Phreesia Inc
NYSE:PHR
|
1.2B USD | 3.3 | -8.5 | -10.1 | -7.9 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | 61.6 | 61.4 | 66.1 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 78.1 | 163.9 | 112.7 | 112.7 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 11.2 | -331.8 | -175.3 | -162.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | 32.2 | 21.5 | 22.9 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.7B SEK | 26.1 | 100.6 | -66.2 | -66.2 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.1 | 26.1 | 277.7 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -319.5 | 34.1 | -111.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
